– USA, NC – Dentsply Sirona Inc (Nasdaq: XRAY) today announced the appointment of John Groetelaars to its Board of Directors, increasing the Board to twelve members.
“We are pleased to welcome John Groetelaars to the Dentsply Sirona Board of Directors. John brings more than 30 years of MedTech experience with 20 years of international experience, including as the former CEO of Hillrom. John’s deep medical technology experience and leadership roles will be a valuable addition to our Board of Directors. We look forward to working with him as we continue to advance patient care through high-quality and innovative dental solutions,” said Board Chairman, Eric Brandt.
About John P. Groetelaars
John Groetelaars served as President, CEO, and a Board member at Hillrom from May 2018 until the company’s acquisition by Baxter International, Inc., in December 2021. At Hillrom, he had enterprise responsibility for a global healthcare technology company with $3 billion in revenue and more than 10,000 employees. Mr. Groetelaars led a transformation of Hillrom’s business, successfully articulating and launching a new connected-car strategy and vision, growing the portfolio through seven acquisitions and one divestiture, and driving record financial performance. In addition, he championed and actively led diversity, inclusion, equity, and belonging initiatives across the company, which led to record levels of employee engagement, and external recognition from DiversityInc, Forbes, and many other organizations. Before Hillrom, Mr. Groetelaars served as EVP and president of the Interventional Segment at Becton, Dickinson and Company, a medical technology company, since December 2017 following its acquisition of C.R. Bard Inc., a medical technology company, where his responsibilities included global strategic, financial, operational and innovation platforms. He previously served in a variety of progressive roles at C.R. Bard during his 10-year career there, including as a group president from 2015 to 2017. Mr. Groetelaars joined C.R. Bard in 2008 as VP and GM, Davol Inc., and was appointed president of Davol in 2009. In 2013, Mr. Groetelaars was promoted to group VP and in 2015 he was promoted to group president, a position he held until C.R. Bard was acquired by Becton, Dickinson, and Company in December 2017. Before joining C.R. Bard, Mr. Groetelaars held various international leadership positions in Canada, Denmark, and the United Kingdom at Boston Scientific Corporation from 2001 until 2008. Before joining Boston Scientific, Mr. Groetelaars held positions in general management, marketing, business development, and sales with Guidant Corporation and Eli Lilly. He was also formerly a director on the AdvaMed board.
About Dentsply Sirona
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 135-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets comprehensive solutions offering dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality, and effective solutions to advance patient care and deliver better, safer, and faster dentistry.
For more information: https://www.dentsplysirona.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.